DERM-MAXX Trademark

Trademark Overview


On Monday, October 9, 2023, a trademark application was filed for DERM-MAXX with the United States Patent and Trademark Office. The USPTO has given the DERM-MAXX trademark a serial number of 98215670. The federal status of this trademark filing is REGISTERED as of Tuesday, March 11, 2025. This trademark is owned by Royal Biologics. The DERM-MAXX trademark is filed in the Pharmaceutical Products category with the following description:

Human allograft tissue
derm-maxx

General Information


Serial Number98215670
Word MarkDERM-MAXX
Filing DateMonday, October 9, 2023
Status700 - REGISTERED
Status DateTuesday, March 11, 2025
Registration Number7725557
Registration DateTuesday, March 11, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 9, 2024

Trademark Statements


Goods and ServicesHuman allograft tissue

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 9, 2023
Primary Code005
First Use Anywhere DateFriday, January 24, 2020
First Use In Commerce DateFriday, January 24, 2020

Trademark Owner History


Party NameRoyal Biologics
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHackensack, NJ 07601

Party NameRoyal Biologics
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHackensack, NJ 07601

Party NameRoyal Biologics
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHackensack, NJ 07601

Trademark Events


Event DateEvent Description
Monday, October 9, 2023NEW APPLICATION ENTERED
Tuesday, December 26, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 1, 2024ASSIGNED TO EXAMINER
Wednesday, March 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 9, 2024PUBLISHED FOR OPPOSITION
Thursday, March 7, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 4, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 7, 2024USE AMENDMENT FILED
Thursday, November 7, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, April 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, January 23, 2025STATEMENT OF USE PROCESSING COMPLETE
Thursday, January 23, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 18, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 18, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 11, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, March 11, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords


maxx derm tissue allograft human